(S)-3,3-Dimethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one, 95.0%, 250mg

N-Succinimidyl 6-[[4-(N-Maleimidomethyl)cyclohexyl]carboxamido]hexanoate (2mg*5)1set

(3-methoxyphenoxy)acetic acid, 95%, 10g

5-Bromo-2,4-dichloro-6-methylpyrimidine, 95.0%, 5g

(R)-7-METHOXY-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE HCL, 95.0%, 250mg

tert-Butyl 3-formylmorpholine-4-carboxylate, 95.0%, 250mg

C-(4-Methoxy-pyridin-2-yl)-)-methylamine, 95.0%, 5g

5-Chloro-2-phenyl-3H-imidazole-4-carbaldehyde, 95.0%, 1g

Benzo[h]quinoline, 98.0%, 5g

lithium 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoate dihydrate, 95%, 250mg

Eriochrome black T indicator (C.I. 14645), 1% solid, 1kg

3-(aminomethyl)-1-methylpyrrolidin-2-one hydrochloride, 95.0%, 250mg

4-Hydroxy-1,5-naphthyridine, 95.0%, 5g